The U.S. Agency for medicines and food products (FDA) issued stern warnings against the use of four drugs to treat arthritis because of its potential serious side effects. drugs, Humira, Cimzia, Enbrel and Remicade, act by weakening the immune system to prevent it from attacking the body.
Pharmaceutical companies responsible for their manufacture have been alerted to the danger of pulmonary fungal infections patients contract, said the FDA (Food and Drug Administration) in a statement.
Of the 240 cases of infection called histoplasmosis brought to the FDA, at least 12 of the patients died, the agency said.
"Under the new FDA authority, require a change in the reporting of warnings and risk assessment," said Dr. Bob Rappaport, an official of the agency.
One such measure that seeks to take more care physicians and to ensure that the benefits of these drugs outweigh the risks, he added.
These four drugs in the category of so-called anti-TNF alpha and are also prescribed to treat Crohn's disease and some psoriasis, a chronic dermatitis.
The manufacturers of these drugs are the Belgian UCB Pharma (Cimzia) and Americans Habbott (Humira), Amgen (Enbrel) and Centocor (Remicade).
Source: 24horaslibre.com
0 comments:
Post a Comment